A case of temporal arteritis associated with mucoromycosis

Journal of Isfahan Medical School

Volumn 27, Issue 92, 2009, Pages

  Meidani, Mohsen ^a   Soheilipour, Saeed ^a   Barzegar, Farzaneh ^a   Heidarpour, Mitra ^a   Shakeri, Heshmatollah ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Amphotricine B; Mucormycosis; Posaconazole; Sinusitis; Temporal artery

Indexed keywords

ANTIFUNGAL AGENT; POSACONAZOLE;

ARTICLE; BIOPSY; CASE REPORT; CLINICAL ARTICLE; DEBRIDEMENT; DIABETIC PATIENT; HEADACHE; HUMAN; KIDNEY FAILURE; MALE; MUCORMYCOSIS; TEMPORAL ARTERITIS; TEMPORAL ARTERY;

EID: 84890844663     PISSN: 10277595     EISSN: 1735854X     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Spellberg B, Edwards J, Jr., Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev 2005; 18(3): 556-69.
2. Madhusudhan KS, Gamanagatti S, Seith A, Hari S. Pulmonary infections mimicking cancer: report of four cases. Singapore Med J 2007; 48(12): e327-e31.
3. Budhiraja S, Sood N, Singla S, Gupta V. Gastrointestinal mucormycosis in a neonate: Survival without antifungal therapy. Indian J Gastroenterol 2007; 26(4): 198.
4. Jemli B, Garsallah H, Lebben I, Ferjeni M, Gargouri S. Cutaneous mucormycosis and diabetes: about one observation. Bull Soc Pathol Exot 2005; 98(5): 347-9.
5. Alleyne CH, Jr., Vishteh AG, Spetzler RF, Detwiler PW. Long-term survival of a patient with invasive cranial base rhinocerebral mucormycosis treated with combined endovascular, surgical, and medical therapies: case report. Neurosurgery 1999; 45(6): 1461-3.
6. Hamilton JF, Bartkowski HB, Rock JP. Management of CNS mucormycosis in the pediatric patient. Pediatr Neurosurg 2003; 38(4): 212-5.
7. Shah PD, Peters KR, Reuman PD. Recovery from rhinocerebral mucormycosis with carotid artery occlusion: a pediatric case and review of the literature. Pediatr Infect Dis J 1997; 16(1):68-71.
8. Rutar T, Cockerham KP. Periorbital zygomycosis (mucormycosis) treated with posaconazole. Am J Ophthalmol 2006; 142(1): 187-8.
9. Goswami R, Tandon N, Thulkar S, Kochupillai N. Diabetes mellitus, fever, proptosis, and rapid loss of vision. Postgrad Med J 1996; 72(852): 633-5.
10. Lowe JT, Jr., Hudson WR. Rhincerebral phycomycosis and internal carotid artery thrombosis. Arch Otolaryngol 1975; 101(2): 100-3.
11. Terk MR, Underwood DJ, Zee CS, Colletti PM. MR imaging in rhinocerebral and intracranial mucormycosis with CT and pathologic correlation. Magn Reson Imaging 1992; 10(1): 81-7.
12. Gonzalez CE, Rinaldi MG, Sugar AM. Zygomycosis. Infect Dis Clin North Am 2002; 16(4): 895-914.
13. Leather HL, Correll TA, Meyer CL, Schmalfuss IM, Wingard JR. Treatment of zygomycosis with posaconazole in a patient with acute myeloid leukemia. Clin Adv Hematol Oncol 2005; 3(10): 773-7.
14. Greenberg RN, Mullane K, van Burik JA, Raad I, Abzug MJ, Anstead G, et al. Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother 2006; 50(1): 126-33.
15. Groll AH, Walsh TJ. Posaconazole: clinical pharmacology and potential for management of fungal infections. Expert Rev Anti Infect Ther 2005; 3(4): 467-87.
16. Courtney R, Pai S, Laughlin M, Lim J, Batra V. Pharmacokinetics, safety, and tolerability of oral posaconazole administered in single and multiple doses in healthy adults. Antimicrob Agents Chemother 2003; 47(9): 2788-95.